Holen Sie sich die Stockscreener-App
105.38
0.03%
-0.02
Schlusskurs vom Vortag:
$105.36
Offen:
$104.64
24-Stunden-Volumen:
852.62K
Relative Volume:
0.17
Marktkapitalisierung:
$155.49B
Einnahmen:
$16.75B
Nettoeinkommen (Verlust:
$1.85B
KGV:
84.30
EPS:
1.25
Netto-Cashflow:
$2.37B
1W Leistung:
-0.74%
1M Leistung:
+4.38%
6M Leistung:
+33.65%
1J Leistung:
+60.19%
1-Tages-Spanne:
$104.42
$105.65
1-Wochen-Bereich:
$102.92
$105.72
52-Wochen-Spanne:
$65.52
$107.17
Boston Scientific Corp Stock (BSX) Company Profile
Firmenname
Boston Scientific Corp
Sektor
Branche
Telefon
508-683-4000
Adresse
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Vergleichen Sie BSX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
105.40 | 155.49B | 16.75B | 1.85B | 2.37B | 1.25 |
|
ABT
Abbott Laboratories
|
134.26 | 230.98B | 41.95B | 13.40B | 6.49B | 7.65 |
|
SYK
Stryker Corp
|
385.54 | 147.45B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.69 | 112.85B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
74.02 | 44.06B | 5.72B | 4.17B | 490.10M | 6.97 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Herabstufung | Needham | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2024-02-01 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-22 | Eingeleitet | Mizuho | Neutral |
| 2022-12-20 | Fortgesetzt | Citigroup | Buy |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-05-27 | Hochstufung | Needham | Hold → Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-05-26 | Herabstufung | Needham | Buy → Hold |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-17 | Eingeleitet | Truist | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-22 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Neutral |
| 2020-02-06 | Fortgesetzt | BTIG Research | Buy |
| 2019-12-30 | Bestätigt | Cowen | Outperform |
| 2019-12-19 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-09-05 | Fortgesetzt | JP Morgan | Overweight |
| 2019-09-03 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-10-02 | Bestätigt | Morgan Stanley | Overweight |
| 2018-09-07 | Bestätigt | Needham | Strong Buy |
| 2018-09-04 | Hochstufung | Jefferies | Hold → Buy |
| 2018-07-06 | Bestätigt | Needham | Strong Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Outperform |
| 2018-04-26 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
Boston Scientific hired 5,000 new employees, increased real estate footprint in 2024 - NBC Boston
Boston Scientific ramped up headcount, real estate footprint in 2024 - The Business Journals
$3.77 Bn Surgical Meshes Market Opportunities and Strategies to 2034: Medtronic Leads the Fragmented Market, Followed by Boston Scientific and Johnson & Johnson - GlobeNewswire Inc.
Boston Scientific Co. (NYSE:BSX) CFO Daniel J. Brennan Sells 67,333 Shares - MarketBeat
Boston Sci obtains CE mark for Farapulse navigation mapping system - BioWorld Online
Boston Scientific Co. (NYSE:BSX) EVP Sells $277,417.37 in Stock - MarketBeat
Boston Scientific Expects Strong Gains in 2025: Time to Buy the Stock? - Nasdaq
Boston Scientific Corp. credit rating upgraded to ’A-’ on strong performance: S&P Global - Investing.com Nigeria
Boston Scientific Corp. credit rating upgraded to 'A-' on strong performance: S&P Global - Investing.com
TKG Advisors LLC Purchases 26,005 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Private Wealth Partners LLC Sells 3,895 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Venturi Wealth Management LLC Buys 5,821 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Truist Financial Corp Has $19.28 Million Stake in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific to participate in TD Cowen's 45th Annual Health Care Conference - Quantisnow
Insider Selling: Boston Scientific Co. (NYSE:BSX) EVP Sells 1,201 Shares of Stock - MarketBeat
Congress Asset Management Co. Has $153.83 Million Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Fitch boosts Boston Scientific's Long-Term IDR to 'A-', maintains stable outlook - Investing.com
Beyond the Balance Sheet: What SWOT Reveals About Boston Scienti - GuruFocus.com
Boston Scientific to participate in TD Cowen's 45th Annual Health Care Conference – Company Announcement - Financial Times
Boston Scientific Co. (NYSE:BSX) Shares Sold by New York State Common Retirement Fund - MarketBeat
Smart Pills Market Deep Research Report with Forecast by 2032 |Boston Scientific Corporation, Olympus Medical - EIN News
Braun Stacey Associates Inc. Lowers Stock Position in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific EVP sells $127,678 in stock By Investing.com - Investing.com Nigeria
Rhumbline Advisers Sells 113,403 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific EVP sells $127,678 in stock - Investing.com India
Boston Scientific Corp Files For Debt Shelf, Size Not Disclosed -February 18, 2025 at 05:53 pm EST - Marketscreener.com
Argus Research Adjusts Price Target on Boston Scientific to $130 From $105 -February 18, 2025 at 08:21 am EST - Marketscreener.com
Boston Scientific Co. (NYSE:BSX) Shares Bought by CIBC Asset Management Inc - MarketBeat
Legacy Capital Wealth Partners LLC Takes Position in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Co. (NYSE:BSX) Shares Sold by Blue Trust Inc. - MarketBeat
Boston Scientific Co. (NYSE:BSX) Shares Purchased by Empowered Funds LLC - MarketBeat
New York State Teachers Retirement System Has $114.79 Million Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Entropy Technologies LP Makes New $214,000 Investment in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Co. (NYSE:BSX) Holdings Increased by Avestar Capital LLC - MarketBeat
Boston Scientific Co. (NYSE:BSX) CFO Sells $1,585,191.09 in Stock - MarketBeat
Boston Scientific Co. (NYSE:BSX) Stake Lessened by Chevy Chase Trust Holdings LLC - MarketBeat
Boston Scientific bags CE marking for Farapulse catheter and software - Yahoo Finance
Boston Scientific wins CE mark for Farapulse Nav mapping tech - Mass Device
Edward J. Ludwig Sells 12,000 Shares of Boston Scientific Co. (NYSE:BSX) Stock - MarketBeat
Covenant Asset Management LLC Makes New $3.41 Million Investment in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Bank Pictet & Cie Europe AG Acquires 21,173 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific EVP sells shares worth $671,249 - MSN
Allspring Global Investments Holdings LLC Has $182.24 Million Position in Boston Scientific Co. (NYSE:BSX) - MarketBeat
G&S Capital LLC Increases Stake in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific's Jeffrey Mirviss sells $1.37 million in stock - MSN
Boston Scientific director Edward Ludwig sells $1.27 million in stock - MSN
AustralianSuper Pty Ltd Has $231.01 Million Position in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Co. (NYSE:BSX) Stock Position Decreased by Banque Pictet & Cie SA - MarketBeat
Vontobel Holding Ltd. Has $501.84 Million Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Louisiana State Employees Retirement System Sells 3,600 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific CFO sells $1.59 million in stock - MSN
Finanzdaten der Boston Scientific Corp-Aktie (BSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.07%
2.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):